Srivastava Sudhir Sells 33,333 Shares of SS Innovations International (NASDAQ:SSII) Stock

Key Points

• CEO Srivastava Sudhir sold 33,333 shares of SS Innovations International at $3.00 each, generating approximately $100,000. He retained 108.5 million shares, and the sale reduced his position by just 0.03%.
• SSII reported quarterly revenue of $13.94 million and a loss of $0.01 per share, alongside a negative net margin of 23.73% and negative return on equity of 26.77%.
• Analyst sentiment remains negative: the stock has a consensus “Sell” rating, despite an average price target of $7.00, while shares recently traded near $3.22—well below the 12-month high of $10.00.

SS Innovations International, Inc. (NASDAQ:SSII - Get Free Report) CEO Srivastava Sudhir sold 33,333 shares of SS Innovations International stock in a transaction on Friday, September 4th. The stock was sold at an average price of $3.00, for a total transaction of $99,999.00. Following the sale, the chief executive officer directly owned 108,520,928 shares in the company, valued at $325,562,784. This trade represents a 0.03% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

SS Innovations International Price Performance

Shares of SSII stock opened at $3.22 on Thursday. SS Innovations International, Inc. has a 12 month low of $3.11 and a 12 month high of $10.00. The firm has a market capitalization of $645.22 million, a P/E ratio of -53.67 and a beta of -1.94. The company's fifty day moving average price is $3.65 and its two-hundred day moving average price is $4.06.

SS Innovations International (NASDAQ:SSII - Get Free Report) last announced its earnings results on Thursday, August 13th. The company reported ($0.01) earnings per share for the quarter. SS Innovations International had a negative net margin of 23.73% and a negative return on equity of 26.77%. The business had revenue of $13.94 million for the quarter.

Hedge Funds Weigh In On SS Innovations International

Several institutional investors have recently modified their holdings of the company. PNC Financial Services Group Inc. bought a new stake in SS Innovations International in the 3rd quarter valued at about $56,000. Jane Street Group LLC acquired a new stake in shares of SS Innovations International in the fourth quarter valued at approximately $63,000. IFC & Insurance Marketing Inc. bought a new stake in shares of SS Innovations International during the fourth quarter valued at approximately $64,000. Goldman Sachs Group Inc. acquired a new position in shares of SS Innovations International during the fourth quarter worth approximately $68,000. Finally, Envestnet Asset Management Inc. bought a new position in SS Innovations International in the 3rd quarter worth approximately $71,000.

Analysts Set New Price Targets

SSII has been the topic of a number of recent analyst reports. Loop Capital set a $7.00 target price on SS Innovations International in a research report on Wednesday, June 3rd. Weiss Ratings reissued a "sell (e+)" rating on shares of SS Innovations International in a research report on Friday, July 17th. Finally, Wall Street Zen upgraded shares of SS Innovations International from a "sell" rating to a "hold" rating in a research note on Sunday, June 28th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company presently has a consensus rating of "Sell" and an average price target of $7.00.

SS Innovations International Company Profile

AVRA Medical Robotics, Inc develops and manufactures medical surgical devices. The company has a research agreement with the University of Central Florida to develop navigation and control technologies with applications in medical robotics. The company was formerly known as AVRA Surgical Microsystems, Inc and changed its name to AVRA Medical Robotics, Inc in November 2015. AVRA Medical Robotics, Inc was founded in 2015 and is based in Orlando, Florida.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.